Vioxx controversy means longer patient encounters
Recent warnings by the Food and Drug Administration (FDA) over use of COX-2 inhibitors, a particular class of non-steroidal anti-inflammatory drugs (NSAIDs) that have...
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.